10709-4

Plasmodium falciparum Ag [Units/volume] in Blood by Immunofluorescence

Active

Part Descriptions

LP14839-2   Plasmodium falciparum
Four species of the Plasmodium protozoa are considered true parasites of humans as they use humans almost exclusively as a natural intermediate host: P. falciparum, P. vivax, P. ovale and P. malariae. Malaria today is usually restricted to tropical and subtropical areas and altitudes below 1,500 m., although in the past malaria was endemic in much of North America, Europe and even parts of northern Asia, and today is still present on the Korean peninsula. However, this present distribution could be affected by climatic changes and population movements. P. falciparum is the most prevalent species and responsible for the most morbidity and mortality worldwide. Early detect is of paramount importance due to the incidence of cerebral malaria and drug resistance. Malarial infections caused by P. falciparum are the most likely to progress to severe, potentially fatal forms with central nervous system involvement (cerebral malaria), acute renal failure, severe anemia, or acute respiratory distress syndrome.[CDC] Source: Regenstrief LOINC, CDC

LP20149-8   Plasmodium
Malaria is a parasitic disease that is passed from one human to another by the bite of an infected Anopheles mosquito with one of four protozoan parasites: Plasmodium falciparum, vivax, malariae or ovale. The parasites enter the bloodstream and infect red blood cells where they multiply and infect more red blood cells. Symptoms usually occur 10 days to 4 weeks after infection and include anemia, high fevers, shaking chills, muscle pain, and nausea. Antimalarial agents used to treat malaria include Quinine, Quinidine, Mefloquine, Chloroquine, and Hydroxychloroquine. The effectiveness of the agents depends on which phase or phases of the Plasmodium life cycle is interrupted. In most cases, treatment outcome is expected to be good except in cases of a p. falciparum infection. Adverse effects from antimalaria medications include vomiting, diarrhea, headaches, cardiac arrhythmias, EKG abnormalities, deafness, damage to liver and kidney and muscle weakness. Source: NMS labs

Fully-Specified Name

Component

Plasmodium falciparum Ag

Property

ACnc

Time

Pt

System

Bld

Scale

Qn

Method

IF

Additional Names

Short Name

P falciparum Ag Bld IF-aCnc

Display Name

P. falciparum Ag IF Qn (Bld)

Consumer Name Alpha Get Info

Plasmodium falciparum antigen, Blood

Basic Attributes

Class

MICRO

Type

Laboratory

First Released

Version 1.0i

Last Updated

Version 2.69

Order vs. Observation

Both

Member of these Groups Get Info

Language Variants Get Info

Related Names

• ACIF
• Anticomplement Immunofluorescence
• Antigen
• Antigens
• Arbitrary concentration
• Blood
• DFA
• FA
• Fluorescent antibody
• Fluoresent
• ID
• IFA
• Immune fluorescence
• Immunoflour
• Immunofluor
• Immunofluorescence
• Infectious Disease
• InfectiousDisease
• Malaria
• Malarial
• Microbiology
• P falciparum
• Point in time
• QNT
• Quan
• Quant
• Quantitative
• Random
• Time Resolved Fluorescence
• TRF
• WB
• Whole blood

Example Units

LOINC Terminology Service (API) using HL7^® FHIR^® Get Info

Requests to this service require a free LOINC username and password. Below is a sample of the possible capabilities. See the LOINC Terminology Service documentation for more information.

CodeSystem lookup

https://fhir.loinc.org/CodeSystem/$lookup?system=http://loinc.org&code=10709-4

LOINC Copyright

Copyright © 2024 Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright © 1995-2024, Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee. See https://loinc.org/license for the full LOINC copyright and license.